Anamorelin全新购买方式一览

Introduction: Anamorelin is a growth hormone receptor agonist that can be administered orally and is believed to improve cancer cachexia by improving appetite and increasing serum insulin-like growth factor-1. Anamorelin is approved in Japan for the treatment of cancer cachexia in four types of cancer, including non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.

A new way to purchase Anamorelin

1. Hospital pharmacies: Anamorelin has been launched in Japan, and patients can purchase Anamorelin directly from Japanese hospital pharmacies.

2. Online pharmacies: Purchasing through online pharmacies is also a feasible way, but you must choose a regular online pharmacy.

3. Medical service institutions: If it cannot be purchased in Japan, patients can purchase Anamorelin through medical service institutions.

4. Consult domestic pharmacies or pharmaceutical agents: You can contact some large domestic pharmacies or pharmaceutical agents to inquire whether you can buy Anamorelin and understand the purchase process and related requirements.

When purchasing Anamorelin, you should choose a reliable purchasing channel, verify its legality and credibility, and understand the relevant information about the drug, including side effects, contraindications, etc.

Efficacy of Anamorelin

A study evaluating the efficacy and safety of anamorelin in a subgroup of Japanese non-small cell lung cancer patients showed that in most subgroups, anamorelin produced greater improvements in LBM (lean body mass from baseline to 12 weeks), body weight, and appetite than placebo.

Anamorelin was also associated with greater LBM, body weight, and appetite response rates compared with placebo in nearly all subgroups. This study of patients with NSCLC cancer cachexia showed sustained improvements in LBM, weight, and appetite in most subgroups of patients treated with anamorelin. The study also showed that anamorelin was well tolerated, with a low incidence of serious adverse reactions in each subgroup, regardless of age and PS.